How to increase efficiency and agility in oncology trials
It’s no secret that pharmaceutical and clinical trial industries are reluctant to adapt to technological changes. This may, at least…
Teckro
Latest in
Teckro
Partner content
Why going digital is the right step for the pharma industry
There are several factors at play that explain this reticence to accept change in the pharma industry. For one, regulatory…
Partner content
How a digital approach to risk management is transforming the pharma industry
When it comes to simplifying clinical trials, the most important change companies can make is to embrace the 21st century…
Partner content
How paper protocols may be harming your clinical trial’s success
Convenient, timely access to clinical trial protocols has long been a problem in the pharmaceutical industry as these critical study…
Partner content
How digital transformation can bring clinical trials into the 21st century
In the digital era, we have gotten used to searching and retrieving almost any information we require within seconds. Because…
Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
Rare disease drug development poses such serious challenges that only 5% of rare diseases have a treatment. However, this troubling…
By